| The
Bush Administration is trying a new tactic in tort reform, one the
New York Times reports as an acknowledged changed in government policy
by the Justice Department. In essence, if the FDA has approved a product,
consumers cannot sue regarding it.
The purpose is to prevent undermining public health by second guessing
the FDA's government approval sanction. This applies to devices
and drugs, based on reports of recent court cases. They have argued
that Federal Law barred the claims because a device was produced
to federal specifications.
They also acknowledged this was a change from a 1997 position,
when they felt states could provide an additional protection to
consumers. The administration is arguing that consumers benefit
because the excessive litigation may cause withdrawal of approved
products and "underutilization of beneficial treatments. The
Bush administration is reported to assert their goal was to vindicate
government authority to regulate medical products. Thsy also are
trying to avoid a patchwork of court created standards across the
country.
It is not clear how many cases this affects, or which. But it is
apparently several, because Representative Maurice D. Hinchey (D),
NY, asserted FDA lawyers had repeatedly intercede in civil suits.
The article lists a series of drug and device cases, across the
country.
This raises the question of what other regulatory relief can occur
in Tort Reform and the Malpractice Crisis.
©
2003, 2004 by Medical Malpractice Defense, FIND All Rights Reserved
|